The Methuselah Foundation, whose mission is “nothing less than to enable humans to live longer, better, and wiser, by defeating age-related disease and suffering”, recently got some flashy press coverage by a TV outfit in Los Angeles, KTLA:
The “organ printing” technology described in the video is by a Methuselah-funded company called Organovo. It is one of several organizations supported by the Methuselah Foundation. Another of it’s organizations is even more exciting: the SENS Foundation:
SENS is an acronym for “Strategies for Engineered Negligible Senescence”. It is best defined as an integrated set of medical techniques designed to restore youthful molecular and cellular structure to aged tissues and organs. Essentially, this involves the application of regenerative medicine to the problem of age-related ill-health. However, regenerative medicine is usually thought of as encompassing a few specific technologies such as stem cell therapy and tissue engineering, whereas SENS incorporates a variety of other techniques to remove or obviate the accumulating damage of aging.
SENS is the brainchild of the famous Aubrey de Grey, author of the book Ending Aging. De Grey spoke at a conference in Edmonton, Alberta a few years ago, and was interviewed by the CBC. See it and are other interviews and media here.
Aubrey de Grey
